Review



crl 2638 panc02 cell bank  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC crl 2638 panc02 cell bank
    Crl 2638 Panc02 Cell Bank, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 3065 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panc02+cells/pm41923628-221-57-75?v=ATCC
    Average 99 stars, based on 3065 article reviews
    crl 2638 panc02 cell bank - by Bioz Stars, 2026-07
    99/100 stars

    Images



    Similar Products

    99
    ATCC crl 2638 panc02 cell bank
    Crl 2638 Panc02 Cell Bank, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panc02+cells/pm41923628-221-57-75?v=ATCC
    Average 99 stars, based on 1 article reviews
    crl 2638 panc02 cell bank - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    94
    CLS Cell Lines Service GmbH murine pancreatic adenocarcinoma cell line panc02
    Murine Pancreatic Adenocarcinoma Cell Line Panc02, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panc02+cells/pm42318705-137-1-23?v=CLS+Cell+Lines+Service+GmbH
    Average 94 stars, based on 1 article reviews
    murine pancreatic adenocarcinoma cell line panc02 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    86
    Procell Inc mouse pancreatic cancer cell line panc02
    Mouse Pancreatic Cancer Cell Line Panc02, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panc02+cells/pm42251943-52-30-39?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    mouse pancreatic cancer cell line panc02 - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Procell Inc murine pancreatic cancer cell line panc02
    Murine Pancreatic Cancer Cell Line Panc02, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panc02+cells/pm42092950-122-3-12?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    murine pancreatic cancer cell line panc02 - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    94
    ATCC 243 panc02 atcc cat
    243 Panc02 Atcc Cat, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panc02+cells/pm41650952-489-78-80?v=ATCC
    Average 94 stars, based on 1 article reviews
    243 panc02 atcc cat - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    86
    Jackson Laboratory 258 murine pancreatic cancer panc02 cells
    258 Murine Pancreatic Cancer Panc02 Cells, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panc02+cells/pm41634799-85-17-27?v=Jackson+Laboratory
    Average 86 stars, based on 1 article reviews
    258 murine pancreatic cancer panc02 cells - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    94
    CLS Cell Lines Service GmbH pan02 mouse pancreatic cancer cells
    (A) Calculated irreversible electroporation (IRE) lethal electric field thresholds for <t>Pan02</t> mouse pancreatic cancer using a 3-dimensional (3D) collagen hydrogel; mean ± SD; n = 5. (B) COMSOL Multiphysics finite element model (FEM) representing subcutaneous mouse tumors with a 5-mm spacing shown. (C) Simulated percent tumor coverage by the lethal electric field using the subcutaneous FEM with randomized tissue conductivities and tumor sizes (4 to 8 mm); mean ± SD; n = 30. (D) In Vivo Imaging System (IVIS) imaging of FLuc-eGFP + Pan02 cells in immunodeficient NOD/SCID/IL2gc-KO (NSG) mice (m) follows complete ablation and subsequent microtumor recurrence after IRE treatment at 2,500 V/cm; n = 6. (E) Tumor scabbing and flattening at day 3 post-treatment. (F) Total photon flux within the tumor region of interest from the IVIS images; mean and range presented; multiple 2-tailed t tests between the data compared to the initial day 0 total photon flux; n = 6. (G) Measured tumor size over time from tumor inoculation; mean and range presented; multiple 2-tailed t tests between the data compared to pre-treatment tumor size on day 30; n = 6. ** P < 0.01; **** P < 0.0001. FLuc-eGFP, firefly-luciferase-enhanced green fluorescent protein. SAT, subcutaneous fat.
    Pan02 Mouse Pancreatic Cancer Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panc02+cells/pmc12862134-177-0-5?v=CLS+Cell+Lines+Service+GmbH
    Average 94 stars, based on 1 article reviews
    pan02 mouse pancreatic cancer cells - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    CLS Cell Lines Service GmbH panc02
    (A) Calculated irreversible electroporation (IRE) lethal electric field thresholds for <t>Pan02</t> mouse pancreatic cancer using a 3-dimensional (3D) collagen hydrogel; mean ± SD; n = 5. (B) COMSOL Multiphysics finite element model (FEM) representing subcutaneous mouse tumors with a 5-mm spacing shown. (C) Simulated percent tumor coverage by the lethal electric field using the subcutaneous FEM with randomized tissue conductivities and tumor sizes (4 to 8 mm); mean ± SD; n = 30. (D) In Vivo Imaging System (IVIS) imaging of FLuc-eGFP + Pan02 cells in immunodeficient NOD/SCID/IL2gc-KO (NSG) mice (m) follows complete ablation and subsequent microtumor recurrence after IRE treatment at 2,500 V/cm; n = 6. (E) Tumor scabbing and flattening at day 3 post-treatment. (F) Total photon flux within the tumor region of interest from the IVIS images; mean and range presented; multiple 2-tailed t tests between the data compared to the initial day 0 total photon flux; n = 6. (G) Measured tumor size over time from tumor inoculation; mean and range presented; multiple 2-tailed t tests between the data compared to pre-treatment tumor size on day 30; n = 6. ** P < 0.01; **** P < 0.0001. FLuc-eGFP, firefly-luciferase-enhanced green fluorescent protein. SAT, subcutaneous fat.
    Panc02, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panc02+cells/10__3390_slash_biology15030240-43-21-22?v=CLS+Cell+Lines+Service+GmbH
    Average 94 stars, based on 1 article reviews
    panc02 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    86
    Procell Inc panc02 pancreatic ductal adenocarcinoma cell line
    (A) Calculated irreversible electroporation (IRE) lethal electric field thresholds for <t>Pan02</t> mouse pancreatic cancer using a 3-dimensional (3D) collagen hydrogel; mean ± SD; n = 5. (B) COMSOL Multiphysics finite element model (FEM) representing subcutaneous mouse tumors with a 5-mm spacing shown. (C) Simulated percent tumor coverage by the lethal electric field using the subcutaneous FEM with randomized tissue conductivities and tumor sizes (4 to 8 mm); mean ± SD; n = 30. (D) In Vivo Imaging System (IVIS) imaging of FLuc-eGFP + Pan02 cells in immunodeficient NOD/SCID/IL2gc-KO (NSG) mice (m) follows complete ablation and subsequent microtumor recurrence after IRE treatment at 2,500 V/cm; n = 6. (E) Tumor scabbing and flattening at day 3 post-treatment. (F) Total photon flux within the tumor region of interest from the IVIS images; mean and range presented; multiple 2-tailed t tests between the data compared to the initial day 0 total photon flux; n = 6. (G) Measured tumor size over time from tumor inoculation; mean and range presented; multiple 2-tailed t tests between the data compared to pre-treatment tumor size on day 30; n = 6. ** P < 0.01; **** P < 0.0001. FLuc-eGFP, firefly-luciferase-enhanced green fluorescent protein. SAT, subcutaneous fat.
    Panc02 Pancreatic Ductal Adenocarcinoma Cell Line, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panc02+cells/pm41565700-379-16-24?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    panc02 pancreatic ductal adenocarcinoma cell line - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    Image Search Results


    (A) Calculated irreversible electroporation (IRE) lethal electric field thresholds for Pan02 mouse pancreatic cancer using a 3-dimensional (3D) collagen hydrogel; mean ± SD; n = 5. (B) COMSOL Multiphysics finite element model (FEM) representing subcutaneous mouse tumors with a 5-mm spacing shown. (C) Simulated percent tumor coverage by the lethal electric field using the subcutaneous FEM with randomized tissue conductivities and tumor sizes (4 to 8 mm); mean ± SD; n = 30. (D) In Vivo Imaging System (IVIS) imaging of FLuc-eGFP + Pan02 cells in immunodeficient NOD/SCID/IL2gc-KO (NSG) mice (m) follows complete ablation and subsequent microtumor recurrence after IRE treatment at 2,500 V/cm; n = 6. (E) Tumor scabbing and flattening at day 3 post-treatment. (F) Total photon flux within the tumor region of interest from the IVIS images; mean and range presented; multiple 2-tailed t tests between the data compared to the initial day 0 total photon flux; n = 6. (G) Measured tumor size over time from tumor inoculation; mean and range presented; multiple 2-tailed t tests between the data compared to pre-treatment tumor size on day 30; n = 6. ** P < 0.01; **** P < 0.0001. FLuc-eGFP, firefly-luciferase-enhanced green fluorescent protein. SAT, subcutaneous fat.

    Journal: Research

    Article Title: Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical Human Pancreatic Cancer Mouse Model

    doi: 10.34133/research.1105

    Figure Lengend Snippet: (A) Calculated irreversible electroporation (IRE) lethal electric field thresholds for Pan02 mouse pancreatic cancer using a 3-dimensional (3D) collagen hydrogel; mean ± SD; n = 5. (B) COMSOL Multiphysics finite element model (FEM) representing subcutaneous mouse tumors with a 5-mm spacing shown. (C) Simulated percent tumor coverage by the lethal electric field using the subcutaneous FEM with randomized tissue conductivities and tumor sizes (4 to 8 mm); mean ± SD; n = 30. (D) In Vivo Imaging System (IVIS) imaging of FLuc-eGFP + Pan02 cells in immunodeficient NOD/SCID/IL2gc-KO (NSG) mice (m) follows complete ablation and subsequent microtumor recurrence after IRE treatment at 2,500 V/cm; n = 6. (E) Tumor scabbing and flattening at day 3 post-treatment. (F) Total photon flux within the tumor region of interest from the IVIS images; mean and range presented; multiple 2-tailed t tests between the data compared to the initial day 0 total photon flux; n = 6. (G) Measured tumor size over time from tumor inoculation; mean and range presented; multiple 2-tailed t tests between the data compared to pre-treatment tumor size on day 30; n = 6. ** P < 0.01; **** P < 0.0001. FLuc-eGFP, firefly-luciferase-enhanced green fluorescent protein. SAT, subcutaneous fat.

    Article Snippet: Pan02 mouse pancreatic cancer cells (Cytion, 300501), AsPC-1 human pancreatic cancer cells (American Type Culture Collection [ATCC], CRL-1682), and Jurkat immortalized human T lymphocytes (ATCC, TIB-152) were cultured in RPMI 1640 medium (Thermo Fisher, 11875093) supplemented with 10% (v/v) fetal bovine serum (Fisher Scientific, FB12999102) and 1% (v/v) 10,000 U/ml penicillin–streptomycin (Gibco, 16140122).

    Techniques: Electroporation, In Vivo Imaging, Imaging, Luciferase